From the Guidelines
Ciprofloxacin-dexamethasone (Cipro-dex) is an appropriate treatment option for acute otitis externa in healthy adults. The standard management includes thorough cleaning of the ear canal followed by topical antimicrobial therapy with or without a steroid component. Cipro-dex combines ciprofloxacin (an antibiotic effective against Pseudomonas aeruginosa and Staphylococcus aureus, the most common causative organisms) with dexamethasone (a steroid that reduces inflammation and associated symptoms) 1.
Key Considerations
- The typical regimen is 4 drops into the affected ear(s) twice daily for 7 days.
- Before application, the ear canal should be gently cleaned of debris if possible, and the patient should lie with the affected ear upward for 30-60 seconds after instillation.
- Alternative treatments include other fluoroquinolone drops (such as ofloxacin), aminoglycoside preparations, or acetic acid solutions.
- Oral antibiotics are generally unnecessary unless there is extension beyond the ear canal or in immunocompromised patients, as noted in the clinical practice guideline 1.
- Pain management with acetaminophen or NSAIDs is often needed during the first few days, with the goal of achieving comfort and reducing the intensity of pain, which can be severe in AOE 1.
Patient Education
- Patients should avoid water exposure during treatment and should not use cotton swabs which can worsen the condition.
- If symptoms don't improve within 48-72 hours of treatment, reevaluation is recommended to assess the response to therapy and adjust the treatment plan as needed 1.
- It is essential to inform patients about the potential side effects of eardrops, such as local rash, itching, irritation, or discomfort, and to instruct them to notify their doctor if they experience any unexpected symptoms or if the drops become painful 1.
Clinical Decision-Making
- The choice of eardrop should be based on factors such as cost, dosing frequency, status of the eardrum, and the doctor's experience, with consideration of the patient's preferences and any prior reactions to ear products or medications 1.
- In cases where the eardrum is perforated or an ear tube is in place, the doctor should select an eardrop that is approved for use in the middle ear to minimize potential complications 1.
From the FDA Drug Label
Ciprofloxacin and dexamethasone otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Externa (AOE) in pediatric (age 6 months and older), adult, and elderly patients due to Staphylococcus aureus and Pseudomonas aeruginosa. Ciprofloxacin and dexamethasone otic suspension is for otic use (ears) only, not for ophthalmic use, or for injection. Instill four drops into the affected ear twice daily, for seven days.
Cipro-Dex (Ciprofloxacin and Dexamethasone Otic Suspension) is appropriate for the acute management of acute otitis externa in healthy adults, as it is indicated for the treatment of AOE in adult patients due to Staphylococcus aureus and Pseudomonas aeruginosa 2, 2, 2.
- The recommended dosage is four drops into the affected ear twice daily, for seven days.
- It is essential to note that Cipro-Dex is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication, and in viral infections of the external canal, including herpes simplex infections and fungal otic infections.
From the Research
Acute Management of Acute Otitis Externa in Healthy Adults
Overview of Treatment Options
- Acute otitis externa is a common condition involving inflammation of the ear canal, typically caused by bacterial infection 3.
- Topical antimicrobials or antibiotics, such as acetic acid, aminoglycosides, polymyxin B, and quinolones, are the treatment of choice in uncomplicated cases 3.
- The addition of topical corticosteroids may help resolve symptoms more quickly 3.
Efficacy of Ciprofloxacin/Dexamethasone (CIP/DEX)
- CIP/DEX otic suspension has been shown to be clinically and microbiologically superior to neomycin/polymyxin B/hydrocortisone (N/P/H) otic suspension in the treatment of mild to severe acute otitis externa 4.
- CIP/DEX has been found to have higher clinical cure rates and microbiologic eradication rates compared to N/P/H 4, 5.
- CIP/DEX has also been shown to provide greater pain relief and reduce inflammation and edema compared to N/P/H 6.
Appropriateness of CIP/DEX for Acute Otitis Externa
- CIP/DEX is an appropriate treatment option for acute otitis externa in healthy adults, particularly for those with intact tympanic membranes 4, 3.
- The choice of treatment should be based on factors such as tympanic membrane status, adverse effect profiles, adherence issues, and cost 3.
- CIP/DEX has been found to be effective against Pseudomonas aeruginosa and Staphylococcus aureus, two common pathogens responsible for acute otitis externa 5, 7.